I think the 2016-2017 release date might be logical projection for North America (since they have to contend with the corrupt FDA), but I really think it will be released much sooner in other countries. Hell, that's why they're conducting their clinical trials overseas. The trials really should be shorter since this treatment is entirely autologous. The reason that Aderans's autologous treatment is taking so long is because they weren't getting any results, not because it wasn't safe. What Replicel has, I believe, is a lot more promising than Aderans.
Yeah, Replicel is definitely looking to exceed the 20% hair regrowth mark; they wouldn't put something out that is simply equal to the shit treatments that are out there today. They are just using 20% as a benchmark so when their hopefully-great results come out, they can say that their treatment far exceeds what is out there today. And btw, I don't believe for a second that finasteride produces 20% regrowth; that's about as false as Rogaine's claim of 85% of men that use it achieve hair regrowth.
That's great news with CB 03 01; I wasn't aware of that.
Yeah, Replicel is definitely looking to exceed the 20% hair regrowth mark; they wouldn't put something out that is simply equal to the shit treatments that are out there today. They are just using 20% as a benchmark so when their hopefully-great results come out, they can say that their treatment far exceeds what is out there today. And btw, I don't believe for a second that finasteride produces 20% regrowth; that's about as false as Rogaine's claim of 85% of men that use it achieve hair regrowth.
That's great news with CB 03 01; I wasn't aware of that.
Comment